Medical Journals

Prediction of Peritoneal Metastasis in Advanced Gastric Cancer by Gene Expression Profiling of the Primary Site.

Authors:
  • Motoori Masaaki
  • Takemasa Ichiro
  • Doki Yuichiro
  • Saito Sakae
  • Miyata Hiroshi
  • Takiguchi Shuji
  • Fujiwara Yoshiyuki
  • Yasuda Takushi
  • Yano Masahiko
  • Kurokawa Yukinori
  • Komori Takamichi
  • Yamasaki Makoto
  • Ueno Noriko
  • Oba Shigeyuki
  • Ishii Shin
  • Monden Morito
  • Kato Kikuya

From: Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, 2-2 Yamadaoka Suita, Osaka 565-0871, Japan.

European journal of cancer (Oxford, England : 1990)

  • Publish Date: Aug 2006
  • ISSN: 0959-8049
  • Volume: 42
  • Issue: 12
  • Pages: 1897-903
  • Medium: Print
  • Language: English
  • Citation (JAMA): Motoori Masaaki, Takemasa Ichiro, Doki Yuichiro, et al. Prediction of Peritoneal Metastasis in Advanced Gastric Cancer by Gene Expression Profiling of the Primary Site.. Eur. J. Cancer Aug 2006;42:1897-903

Abstract

Peritoneal metastasis is the most common cause of tumour progression in advanced gastric cancer. Clinicopathological findings including cytologic examination of peritoneal lavage have been applied to assess the risk of peritoneal metastasis, but are sometimes inadequate for predicting peritoneal metastasis in individuals. Hence, we tried to construct a new prediction system for peritoneal metastasis by using a PCR-based high throughput array with 2304 genes. The prediction system, constructed from the learning set comprised of 30 patients with the most informative 18 genes, classified each case into a ‘good signature group’ or ‘poor signature group’. Then, we confirmed the predictive performance in an additional validation set comprised of 24 patients, and the prediction accuracy for peritoneal metastasis was 75%. Kaplan-Meier analysis with peritoneal metastasis revealed significant difference between these two groups (P=0.0225). By combining our system with conventional clinicopathological factors, we can identify high risk cases for peritoneal metastasis more accurately.

Mesh Headings (Keywords): Aged, Disease-Free Survival, Female, Gene Expression Profiling, Humans, Male, Middle Aged, Peritoneal Neoplasms, Predictive Value of Tests, Risk Factors, Stomach Neoplasms


Check for Full Text / PubMed Unique Identifier (PMID): 16831544


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.